Halozyme Therapeutics (HALO) operating margin

Operating margin · fiscal 2025
57.5%

Halozyme Therapeutics (HALO) had an operating margin of 57.5% in fiscal 2025 (the year ended December 31, 2025). That is 3.2 percentage points higher than the 54.3% of fiscal 2024. Figures as of 17 Nov 2026, 22:13 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2025
57.5%
Change on fiscal 2024
+3.2 pts
Highest on record
62.2%fiscal 2021
Lowest on record
-427.6%fiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Halozyme Therapeutics operating margin, in more detail

Across the 17 fiscal years on record (2009–2025), the highest was 62.2% in fiscal 2021 and the lowest -427.6% in fiscal 2009. The fiscal 2025 figure is higher than in 94% of the 16 earlier fiscal years on record, whose median is -34.9%.

Gross margin was 83.6% in fiscal 2025. Net margin was 22.7% in fiscal 2025.

History · 17 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

Halozyme Therapeutics operating margin, year by year

Halozyme Therapeutics (HALO) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
202557.5% 3.2 pts up83.6%22.7%
202454.3% 13.6 pts up84.3%43.7%
202340.7% 0.2 pts up76.8%34.0%
202240.5% 21.7 pts down78.9%30.6%
202162.2% 8.3 pts up—90.8%
202053.9% 88.4 pts up—48.2%
2019-34.5% 11.2 pts up—-36.9%
2018-45.7% 71.2 pts down—-52.9%
201725.6% 82.3 pts up—19.9%
2016-56.7% 36.4 pts down—-70.2%
2015-20.3% 63.3 pts up—-23.9%
2014-83.7% 63.1 pts up—-90.8%
2013-146.8% 20.1 pts down—-152.3%
2012-126.7% 91.3 pts down—-126.5%
2011-35.4% 362.9 pts up—-35.2%
2010-398.2% 29.4 pts up—-390.8%
2009-427.6%——-426.9%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Halozyme Therapeutics and comparable companies
CompanyOperating marginFiscal year
Fresenius Medical Care FMS9.3%2025
Kymera Therapeutics KYMR-881.2%2025
DaVita DVA14.7%2025
Halozyme Therapeutics HALO57.5%2025
Universal Health Services UHS11.5%2025
Repligen RGEN5.6%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on HALO

Halozyme Therapeutics, figure by figure

Halozyme Therapeutics (HALO) overview: price, valuation and scorecardAll health care companies by market value

Halozyme Therapeutics operating margin: questions and answers

What is Halozyme Therapeutics's operating margin?

Halozyme Therapeutics (HALO) had an operating margin of 57.5% in fiscal 2025 (the year ended December 31, 2025). That is 3.2 percentage points higher than the 54.3% of fiscal 2024.

Is Halozyme Therapeutics's operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in 94% of the 16 earlier fiscal years on record, whose median is -34.9%.

What are the highest and lowest operating margin figures on record for Halozyme Therapeutics?

Across the 17 fiscal years on record (2009–2025), the highest was 62.2% in fiscal 2021 and the lowest -427.6% in fiscal 2009.

What are Halozyme Therapeutics's gross and net margins?

Gross margin was 83.6% in fiscal 2025. Net margin was 22.7% in fiscal 2025.

How is Halozyme Therapeutics's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Halozyme Therapeutics (HALO) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/HALO/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.